The University of Washington Alzheimer's Disease Patient Registry (ADPR) is a model clinical and epidemiologic database for dementia and dementia of the Alzheimer's type (DAT). It was established in late 1986 by a grant from the National Institute on Aging and is based in a large health maintenance organization -- Group Health Cooperative of Puget Sound (GHC). The ADPR enrolls only those cases of dementia and DAT who have come to medical attention since 1 January 1987; providing each of the potential cases with a standardized, physical, neurological and neuropsychological examination leading to a criteria-based diagnosis. The goal of this application is to continue the model ADPR for another three years so that additional cases can be enrolled; additional cases will allow ongoing epidemiologic/genetic studies to proceed and make future investigations feasible.
The specific aims of the project are: 1. To identify GHC patients who come to medical attention for (previously undiagnosed) dementia and to provide each of these patients with a standardized, thorough examination for dementia and to assign based on established criteria; 2. To enroll the identified patients in the ADPR and to maintain a detailed database including epidemiologic, clinical and family history data; this database will provide cases for other investigations especially concerning diagnosis, etiology and risk factors for DAT and other dementias; 3. To describe the course of dementia, in particular DAT, in terms of cognitive and functional decline, survival and clinical- pathologic correlations. 4. To compare the annual case identification rate of dementia and DAT from the GHC population base with published estimates of incidence.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AG006781-05
Application #
3546261
Study Section
Aging Review Committee (AGE)
Project Start
1986-09-30
Project End
1993-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Harding, Barbara N; Weiss, Noel S; Walker, Rod L et al. (2018) Proton pump inhibitor use and the risk of fractures among an older adult cohort. Pharmacoepidemiol Drug Saf 27:596-603
Keene, C Dirk; Wilson, Angela M; Kilgore, Mitchell D et al. (2018) Luminex-based quantification of Alzheimer's disease neuropathologic change in formalin-fixed post-mortem human brain tissue. Lab Invest :
Flanagan, Margaret E; Larson, Eric B; Walker, Rod L et al. (2018) Associations between Use of Specific Analgesics and Concentrations of Amyloid-? 42 or Phospho-Tau in Regions of Human Cerebral Cortex. J Alzheimers Dis 61:653-662
Gray, Shelly L; Anderson, Melissa L; Hanlon, Joseph T et al. (2018) Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort. J Alzheimers Dis 65:607-616
Marcum, Zachary A; Walker, Rod; Bobb, Jennifer F et al. (2018) Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study. J Am Geriatr Soc 66:2344-2352
Moreno, Monica A; Or-Geva, Noga; Aftab, Blake T et al. (2018) Molecular signature of Epstein-Barr virus infection in MS brain lesions. Neurol Neuroimmunol Neuroinflamm 5:e466
Condello, Carlo; Lemmin, Thomas; Stöhr, Jan et al. (2018) Structural heterogeneity and intersubject variability of A? in familial and sporadic Alzheimer's disease. Proc Natl Acad Sci U S A 115:E782-E791
Gray, Shelly L; Hart, Laura A; Perera, Subashan et al. (2018) Meta-analysis of Interventions to Reduce Adverse Drug Reactions in Older Adults. J Am Geriatr Soc 66:282-288
Bagi, Zsolt; Brandner, Dieter D; Le, Phuong et al. (2018) Vasodilator dysfunction and oligodendrocyte dysmaturation in aging white matter. Ann Neurol 83:142-152
Locke, Timothy M; Soden, Marta E; Miller, Samara M et al. (2018) Dopamine D1 Receptor-Positive Neurons in the Lateral Nucleus of the Cerebellum Contribute to Cognitive Behavior. Biol Psychiatry 84:401-412

Showing the most recent 10 out of 277 publications